BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20240926T110000
DTEND;TZID=UTC:20240926T123000
DTSTAMP:20260610T125818
CREATED:20240821T172900Z
LAST-MODIFIED:20241024T183100Z
UID:10000795-1727348400-1727353800@staging.digitalinsights.supremeclients.com
SUMMARY:Third Annual Clinical Hereditary Disease Diagnostics Summit "Exome experts: Improving the interpretation and integration of exome testing in routine clinical care"
DESCRIPTION:Industry leaders discuss how to improve the speed\, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases \nClinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine\, leading to earlier diagnoses\, targeted treatments and improved patient outcomes. However\, without the right strategies\, databases and informatics tools\, clinical exome testing remains inaccessible for many small to mid-sized laboratories. \nThe Third Annual Clinical Hereditary Disease Diagnostics Summit hosted by QIAGEN Digital Insights will examine the incredible opportunities—and challenges—of brining clinical exome testing in-house. Join industry leaders as they discuss how labs\, regardless of size\, budget and experience\, can integrate exome testing into routine clinical care with transformative impact for providers and their patients. \nFeatured topics will include: \n\nEmerging trends and recent technological advancements in genetic testing\nOvercoming challenges of interpreting complex genetic data from genome\, exome\, and next-generation sequencing panels\nHow to integrate genetic testing into clinical practice with consideration of efficiency\, cost\, and ethics\nFuture directions for the field and how to prepare your lab for innovation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exome-experts-improving-the-interpretation-and-integration-of-exome-testing-in-routine-clinical-care/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240926T130000
DTEND;TZID=America/Halifax:20240926T143000
DTSTAMP:20260610T125818
CREATED:20240814T192314Z
LAST-MODIFIED:20241024T183059Z
UID:10000794-1727355600-1727361000@staging.digitalinsights.supremeclients.com
SUMMARY:Investigating biomarkers with bulk and single-cell RNA-seq expression data
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and compare different types of 'omics data. In this webinar\, we’ll compare bulk RNA-seq and single-cell RNA-seq data to identify common regulators/targets and see how those regulators/targets associate with your phenotype of interest. We will also use sample-level public data to validate gene expression of common genes in tissues and/or cell type of interest. \nYou'll learn how to: \n\nGenerate a Comparison Analysis for bulk and single-cell RNA-seq\nIdentify significant common genes with the Compare feature\nBuild a custom network associating common genes to a phenotype\nExamine sample- and cell-level expression in OmicSoft content
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/compare-bulk-rnaseq-and-single-cell-rnaseq-expression-data-for-biomarkers-investigation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9978_QDI_IPA_Gi609807396_16x9_Medium-720px_50570.jpg
END:VEVENT
END:VCALENDAR